hepatomiR cACLD Study
Recruiting · NCT06432582 · Observational (researchers observe without assigning treatment)
View the official record on ClinicalTrials.gov →Interventions studied
hepatomiR
What this trial is about
This study looks to gather data on hepatomiR, a CE-certified test already intended for gauging liver-related outcomes, in order to define a cut-off regarding specific decompensation events (ascites, variceal hemorrhage, hepatic encephalopathy) in chronic liver disease (CLD). Based on these data, it is aimed to advance the current understanding of factors driving decompensation, with potential repercussions for future risk management and therapy.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Age ≥ 18 years
- Chronic liver disease (more than 6 months)
- LSM ≥ 10 kPa
- Outpatient at the Clinical Department of Internal Medicine II, University Hospital St. Pölten
- Signed patient consent form
Exclusion criteria
- Age older than 18 years
- Pregnancy
- Primary hepatic malignancy (hepatocellular carcinoma, cholangiocarcinoma) with portal invasion and/or extrahepatic spread
Where it is running
1 location listed.
- University Hospital St. Pölten - Sankt Pölten, Lower Austria, Austria